Bright Health Group, Inc. (BHG)
NYSE: BHG · IEX Real-Time Price · USD
1.81
0.07 (4.02%)
At close: May 27, 2022 4:00 PM
1.85
0.04 (2.21%)
After-hours:May 27, 2022 7:59 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue | 4,029.39 | 1,207.32 | 280.67 | 130.63 |
| Revenue Growth (YoY) | 233.75% | 330.15% | 114.86% | - |
| Cost of Revenue | 3,953.67 | 1,047.3 | 224.39 | 96.41 |
| Gross Profit | 75.72 | 160.02 | 56.29 | 34.23 |
| Selling, General & Admin | 1,238.39 | 409.33 | 180.49 | 95.84 |
| Other Operating Expenses | 35.48 | 8.29 | 1.13 | 1.03 |
| Operating Expenses | 1,273.87 | 417.62 | 181.62 | 96.87 |
| Operating Income | -1,198.16 | -257.6 | -125.34 | -62.64 |
| Interest Expense / Income | 7.96 | 0 | 0 | 0 |
| Other Expense / Income | 5.27 | 0 | 0 | 0 |
| Pretax Income | -1,211.38 | -257.6 | -125.34 | -62.64 |
| Income Tax | -26.52 | -9.16 | 0 | 0 |
| Net Income | -1,184.86 | -248.44 | -125.34 | -62.64 |
| Net Income Common | -1,184.86 | -248.44 | -125.34 | -62.64 |
| Shares Outstanding (Basic) | 392 | 136 | 134 | 132 |
| Shares Outstanding (Diluted) | 392 | 136 | 134 | 132 |
| Shares Change | 188.01% | 1.27% | 1.90% | - |
| EPS (Basic) | -3.02 | -1.82 | -0.93 | -0.47 |
| EPS (Diluted) | -3.02 | -1.82 | -0.93 | -0.47 |
| Free Cash Flow Per Share | 0.13 | -0.47 | -0.07 | -0.21 |
| Gross Margin | 1.88% | 13.25% | 20.05% | 26.20% |
| Operating Margin | -29.74% | -21.34% | -44.66% | -47.95% |
| Profit Margin | -29.41% | -20.58% | -44.66% | -47.95% |
| Free Cash Flow Margin | 1.28% | -5.28% | -3.21% | -21.23% |
| Effective Tax Rate | 2.19% | 3.56% | 0.00% | 0.00% |
| EBITDA | -1,167.94 | -249.31 | -124.2 | -61.61 |
| EBITDA Margin | -28.99% | -20.65% | -44.25% | -47.16% |
| EBIT | -1,203.43 | -257.6 | -125.34 | -62.64 |
| EBIT Margin | -29.87% | -21.34% | -44.66% | -47.95% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).